ANALYTICA Analytico's lead product is the: Pe:riCcrach® System- ane--health treatmen1systemfar women who suffer S1ress Urinary lncontinenc:a This affects lin 3 women worldwide and is mostly caused by 1rauma 1a the f}elvicfloor muscles:as a resultat pregnancy, childbirth and menopause.
PeriCoach comprises a device, web p.ortal and smartphane app. The device evaluatesactivity in pelvic floor muscles. This informationis transmitted 1o a smartphone app and can be loaded ta PeriClaud where physicians am monitor patientprogress: via web ponal. Thisnovel system enables physidans1a remotely determineif-a woman is performing her pelvicflaar exercises and if-these are improving her condi1ion.
PeriCaach has regulatory dearonce: in Australia, and has CE mark and USFDA 510!k) clearance:. The productisavailable far sale in Australia and New Zealand, UK and Ireland,and inthe USA by prescription.
GPO Box 670 Brisbane 4001 Qill Australia I t +61 7 32781950
www.pericaach.comwww.analyticamedical.com
Analytica Limited issued this content on 28 April 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 28 April 2016 23:52:00 UTC
Original Document: http://www.analyticamedical.com/downloads/2016/20160428-ASX-ALT-s708A.pdf
